Cure My Disease

Don't miss your cure!

 Log in / Sign up

New dental membrane monitored for better healing after surgery

NCT ID NCT06467630

Knowledge-focused Sponsor: Septodont Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study watches how well a special synthetic membrane helps gums heal after dental procedures like tooth extraction or implant placement. About 90 adults will be followed for months with check-ups and photos. The goal is to see how safely and effectively the membrane supports tissue regrowth in real-world practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

May 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Eligible patients are any male and female, adult patients with one of the 3 following dental treatments to be done with the study device: * post-extraction socket preservation\*, * alveolar ridge augmentation\*, * Guided Tissue Regeneration (GTR) during immediate implant placement. The dental treatment under investigation for one patient could be related to: * 1 alveolar socket corresponding to only 1 tooth; * 1 implant to be placed in replacement of 1 tooth; * several contiguous alveolar sockets; * Or, several contiguous implants to be placed. Dental treatments done simultaneously in non-contiguous dental zones won't be considered for this study.

Ages

18 to 89 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female adult patient * Patient with one of the 3 following dental treatments to be done with the study device: post-extraction socket preservation, alveolar ridge augmentation, or Guided Tissue Regeneration (GTR) during immediate implant placement. * Patient affiliated or beneficiary of a social security system. * Patient has signed his/her informed consent form. Exclusion Criteria: * Pregnancy or lactation * Active tissue infection at the implant site * Several dental treatments done simultaneously in non-contiguous dental zones * Heavy smoker (\>10 cigarettes / day) * Patient receiving long-term corticosteroid therapy, anti-rejection drugs, bisphosphonates, head \& neck radiotherapy or chemotherapy * Patient with chronic infections (such as osteomyelitis) at the surgical site * Patient with poorly controlled metabolic disorders (such as diabetes, osteomalacia, thyroid disorders) * Patient with an auto-immune disease * Patient under tutelage, vulnerable person, person without liberty, or unable to complete questionnaire independently

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Guided bone regeneration are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Guided bone regeneration

Contacts and locations

Locations

  • Hospital University of Nantes

    Nantes, 44000, France

  • Private dental practice office of Dr. Alain Hoornaert

    Nantes, 44000, France

  • Private dental practice office of Dr. Aurélien Fruchet

    Olonne-sur-Mer, 85340, France

  • Private dental practice office of Dr. Edouard Lanoiselée

    Nozay, 44170, France

  • Private dental practice office of Dr. Hélène Le Hécho

    Orée d'Anjou, 49530, France

  • Private dental practice office of Dr. Nicolas Strube

    Orvault, 44700, France

  • Private dental practice office of Dr. Romain Besnier

    Orvault, 44700, France

  • Private dental practice office of Dr. Samer Saloum-Rouxel

    Nantes, 44000, France

  • Private dental practice office of Dr. Xavier Struillou

    Nantes, 44000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.